REward SYSTem in Autism Spectrum Disorder and Addictive Disorder
Launched by UNIVERSITY HOSPITAL, TOURS · May 20, 2022
Trial Information
Current as of May 30, 2025
Recruiting
Keywords
ClinConnect Summary
The REward SYSTem clinical trial is studying how the brains of adults with Autism Spectrum Disorder (ASD) and those with Food Addiction Disorder (FAD) work compared to healthy individuals. This research aims to better understand the differences in brain function and structure among these groups. The trial is currently looking for adult participants aged 18 and older who fall into one of three categories: adults diagnosed with ASD, adults diagnosed with food addiction, or healthy volunteers with no history of neurological or psychiatric issues.
To participate, individuals must have an IQ above 70 and be able to follow instructions during activities. Participants will undergo MRI scans, which are safe imaging tests that allow researchers to see inside the brain. It's important to note that certain health conditions, like serious visual problems or epilepsy, may prevent someone from joining the trial. If you or a loved one meets the criteria and is interested, this study could provide valuable insights into how these disorders affect brain function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Arm A ˗ Concerning ASD patients: Adult carrying the diagnosis of ASD (DSM-5, ADOS, ADI-R criteria)
- • Arm B ˗ Concerning FAD patients: Adult diagnosed with FA presenting with food addiction (DSM-5, YFAS 2.0, BES \>= 18 criteria).
- • Arm C ˗ Concerning healthy volunteers : Adult with no neurological and psychiatric history , absence of progressive somatic pathologies or with vital risk.
- For all participants:
- • Age greater than or equal to 18 years old
- • Without intellectual delay (IQ \> 70).
- • Able to understand and apply the instruction when an active task is proposed, according to the estimate of the investigator.
- • Free, express, informed and written consent of the participant.
- • Participant affiliated to a social security scheme
- Exclusion Criteria:
- • Neuromotor disorders.
- • Visual disturbances not corrected or incompatible with MRI.
- • Known epilepsy.
- • Current substance use disorder with emotional distress/significant impact on functional outcome
- • Rare genetic syndrome.
- • Contraindications to MRI (other than body circumference)
- • For women of childbearing age: negative urine or blood pregnancy test
- • Person subject to a measure of judicial protection (safeguard of justice, curatorship, guardianship or family authorization)
About University Hospital, Tours
The University Hospital of Tours, a leading academic medical institution in France, is dedicated to advancing healthcare through innovative clinical research and patient-centered care. With a strong emphasis on collaboration between researchers, clinicians, and community partners, the hospital fosters a dynamic environment for conducting high-quality clinical trials across various medical disciplines. Its commitment to excellence in patient safety, ethical standards, and scientific integrity positions the University Hospital of Tours as a pivotal contributor to the development of new therapies and health solutions, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tours, , France
Tours, , France
Tours, , France
Patients applied
Trial Officials
Frédéric BRIEND, PhD
Principal Investigator
University Hospital,Tours -INSERM U1253 iBrain
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials